Trk Receptor Inhibitors

TrkA

TrkB

TrkC

Trk

Trk Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	TrkA	TrkB	TrkC	Trk	Purity
ANA-12		TrkB			99.90%
Larotrectinib	TrkA	TrkB	TrkC		99.95%
7,8-Dihydroxyflavone		TrkB			99.90%
Repotrectinib	TrkA				99.93%
Sitravatinib	TrkA, IC₅₀: 5 nM	TrkB, IC₅₀: 9 nM			99.57%
N-Acetyl-5-hydroxytryptamine		TrkB			99.96%
Amitriptyline hydrochloride	TrkA	TrkB			99.94%
GW 441756	TrkA, IC₅₀: 2 nM				99.95%
Lestaurtinib	TrkA, IC₅₀: 25 nM				99.17%
LM22B-10		TrkB	TrkC		99.92%
Tiagabine hydrochloride		TrkB			99.44%
Cyclotraxin B		TrkB			98.11%
Selitrectinib	TrkA, IC₅₀: 0.6 nM		TrkC, IC₅₀: <2.5 nM		99.90%
GNF-5837	TrkA, IC₅₀: 11 nM	TrkB, IC₅₀: 9 nM	TrkC, IC₅₀: 7 nM		99.44%
Altiratinib	Trk1, IC₅₀: 0.85 nM	Trk2, IC₅₀: 4.6 nM	Trk3, IC₅₀: 0.93 nM		98.05%
Larotrectinib sulfate	TrkA	TrkB	TrkC		98.96%
Tamnorzatinib	TrkA				98.59%
AZ-23	TrkA, IC₅₀: 2 nM	TrkB, IC₅₀: 8 nM			98.92%
Tavilermide	TrkA				99.57%
HIOC		TrkB			99.94%
PF-06273340				TRK	98.8%
Tyrphostin AG 879	TrkA				99.85%
Belizatinib	TrkA	TrkB	TrkC		99.64%
Paltimatrectinib	TrkA				99.45%
Levomilnacipran hydrochloride		TrkB			99.95%
Cannflavin B		TrkB			98.36%
PF-6683324	TrkA, IC₅₀: 1.9 nM (in cell-based assays)	TrkB, IC₅₀: 2.6 nM (in cell-based assays)	TrkC, IC₅₀: 1.1 nM (in cell-based assays)		99.41%
CH7057288				TRK	99.73%
TrkA-IN-4	TrkA				99.90%
Amitriptyline hydrochloride (Standard)	TrkA	TrkB			99.03%
DS-1205b free base	TrkA, IC₅₀: 407 nM				99.92%
TrkA-IN-3	TrkA, IC₅₀: 22.4 nM				98.46%
TrkA-IN-1	TrkA, IC₅₀: 99 nM	TrkB, IC₅₀: 81 μM	TrkC, IC₅₀: 25 μM
PF-06737007	TrkA, IC₅₀: 7.7 nM (in cell-based assays)	TrkB, IC₅₀: 15 nM (in cell-based assays)	TrkC, IC₅₀: 3.9 nM (in cell-based assays)		99.70%
CE-245677	TrkA				98.14%
Sitravatinib malate	TrkA, IC₅₀: 5 nM	TrkB, IC₅₀: 9 nM
LPM4870108	TrkA, IC₅₀: 2.4 nM		TrkC, IC₅₀: 0.2 nM
FLT3/TrKA-IN-1	TrkA, IC₅₀: 23.6 nM
IHMT-TRK-284	TrkA, IC₅₀: 10.5 nM	TrkB, IC₅₀: 0.7 nM	TrkC, IC₅₀: 2.6 nM
TRK II-IN-1	TrkA, IC₅₀: 3.3 nM	TrkB, IC₅₀: 6.4 nM	TrkC, IC₅₀: 4.3 nM
CZS-241	TrkA, IC₅₀: 2.74 μM
D5261	TrkA
Trk-IN-8	TrkA		TrkC
JND4135	TrkA	TrkB	TrkC
Cyclotraxin B TFA		TrkB
Trk-IN-11	TrkA
TIY-7	TrkA, IC₅₀: 2.9 nM
Anizatrectinib	TrkA
Type II TRK inhibitor 1	TrkA		TrkC
FLY26		TrkB
(R)-Larotrectinib	TrkA, IC₅₀: 28.5 nM
Multi-kinase-IN-6	TrkA, IC₅₀: 0.33 μM
Trk-IN-20	TrkA, IC₅₀: 1.6 nM	TrkB, IC₅₀: 2.9 nM	TrkC, IC₅₀: 2.0 nM
KRC-108	TrkA, IC₅₀: 39 nM
Pan-Trk-IN-3	TrkA, IC₅₀: 2 nM	TrkB, IC₅₀: 3 nM	TrkC, IC₅₀: 2 nM
TrkC-IN-1			TrkC
Protein kinase inhibitor 5 sulfate hydrate	TrkA, IC₅₀: 1.8 nM
TrkB-IN-1		TrkB
Protein kinase inhibitor 5	TrkA, IC₅₀: 1.8 nM
TRK-IN-23	TrkA, IC₅₀: 0.5 nM TRKA^G595R, IC₅₀: 14 nM TRKA^F589L, IC₅₀: 4.4 nM TRKA^G667C, IC₅₀: 4.8 nM		TrkC, IC₅₀: 9 nM
Trk-IN-7	TrkA, IC₅₀: <25 nM	TrkB, IC₅₀: <5 nM	TrkC, IC₅₀: <25 nM
Trk-IN-10	TrkA
BNN-20		TrkB
ONO-7579	TrkA
HS-345	TrkA
NMS-P626	TrkA, IC₅₀: 8 nM	TrkB, IC₅₀: 3 nM	TrkC, IC₅₀: 7 nM
PF-06733804	TrkA, IC₅₀: 8.4 nM (in cell-based assays)	TrkB, IC₅₀: 6.2 nM (in cell-based assays)	TrkC, IC₅₀: 2.2 nM (in cell-based assays)

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4